Sustained Improvement in Signs and Symptoms of Atopic Dermatitis in Adolescents and Adults Initiating Dupilumab in Real-World Practice: 5-Year Completer Interim Analysis From the PROSE Registry
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s874
DOI: 10.25251/ekns3r56 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Chrins Jojo und 7 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
N/A
Zitieren
APA
Jojo, C., Lima, H. C., Fonacier, L., Lockshin, B., Nguyen, T. Q., Ma, Y., Bosman, K., & Korotzer, A. (2026). Sustained Improvement in Signs and Symptoms of Atopic Dermatitis in Adolescents and Adults Initiating Dupilumab in Real-World Practice: 5-Year Completer Interim Analysis From the PROSE Registry. SKIN The Journal of Cutaneous Medicine, 10(6), s874. https://doi.org/10.25251/ekns3r56
Vancouver
Jojo C, Lima HC, Fonacier L, Lockshin B, Nguyen TQ, Ma Y, et al. Sustained Improvement in Signs and Symptoms of Atopic Dermatitis in Adolescents and Adults Initiating Dupilumab in Real-World Practice: 5-Year Completer Interim Analysis From the PROSE Registry. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s874. doi:10.25251/ekns3r56
BibTeX
@article{Jojo2026,
author = {Jojo, Chrins and Lima, Hermenio C. and Fonacier, Luz and Lockshin, Benjamin and Nguyen, Tien Q. and Ma, Yonghao and Bosman, Kwinten and Korotzer, Andrew},
title = {Sustained Improvement in Signs and Symptoms of Atopic Dermatitis in Adolescents and Adults Initiating Dupilumab in Real-World Practice: 5-Year Completer Interim Analysis From the PROSE Registry},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s874},
doi = {10.25251/ekns3r56}
}
EUVIMED